Figure S4 Found at: doi:10.1371/journal.pone.0005273.s004 (0.12 MB TIF) Figure S5 Found at: doi:10.1371/journal.pone.0005273.s005 (0.24 MB TIF) Figure S6 Found at: doi:10.1371/journal.pone.0005273.s006 (0.24 MB TIF) Figure S7 Found at: doi:10.1371/journal.pone.0005273.s007 (0.16 MB TIF) Figure S8 Found at: doi:10.1371/journal.pone.0005273.s008 (0.07 MB TIF) Figure S9 Found at: doi:10.1371/journal.pone.0005273.s009 (0.08 DOC) Figure S10 Found at: doi:10.1371/journal.pone.0005273.s010 (0.19 MB TIF) Figure S11 Found at: doi:10.1371/journal.pone.0005273.s011 (0.43 MB TIF) Text S1 Supporting Results Found at: doi:10.1371/journal.pone.0005273.s012 (0.07 DOC) Table S1 Found at: doi:10.1371/journal.pone.0005273.s013 (0.03 DOC) MB MB MB References 1. Monneaux F, Briand JP, Muller S (2000) B and T cell immune response to snRNP in lupus mice. Autoreactive CD4+ T cells recognize a T cell epitope located within the conserved RNP consensus sequence of the 70K protein. Eur J Immunol 20: 2191–2200. 2. Monneaux F, Dumortier H, Steiner G, Briand JP, Muller S (2001) Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Faslpr and (NZBxNZW)F1 lupus mice. Intern Immunol 13: 1155–1163. 3. Monneaux F, Lozano JM, Patarroyo ME, Briand JP, Muller S (2003) T cell recognition and therapeutic effects of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MRL/lpr lupus mice. Eur J Immunol 33: 287–296. 4. Monneaux F, Hoebeke J, Sordet C, Nonn C, Briand JP, et al. (2005) Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analogue. J Immunol 175: 5839–5847. 5. Monneaux F, Parietti V, Briand JP, Muller S (2004) Intramolecular T cell spreading in unprimed MRL/lpr mice: Importance of the U1-70K protein sequence 131-151. Arthritis Rheum 50: 3232–3238. 6. Monneaux F, Parietti V, Briand JP, Muller S (2007) Importance of spliceosomal RNP1 motif for intermolecular T-B cell spreading and tolerance restoration in lupus. Arthritis Res Ther 9: R111. 7. Muller S, Monneaux F, Schall N, Rashkov RK, Oparanov BA, et al. (2008) Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus. Results of an early phase II clinical trial. Arthritis Rheum 58: 3873–3883. 8. O’Brien RL, Roark CL, Jin N, Aydintug MK, French JD, et al. (2007) cd T-cell receptors: functional correlations. Immunol Rev 215: 77–88. 9. Tamura Y, Tsuboi N, Sato N, Kikuchi K (1993) 70 kDa heat shock cognate protein is a transformation-associated antigen and a possible target for the host’s anti-tumor immunity. J Immunol 151: 5516–5524. 10. Wei Y, Zhao X, Kariya Y, Fukata H, Teshigawara K, et al. (1996) Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70. Cancer Res 56: 1104–1110. 11. Peng SL, Madaio MP, Hayday AC, Craft J (1996) Propagation and regulation of systemic autoimmunity by cd T cells. J Immunol 157: 5689–5698. 12. Hayday A, Tigelaar R (2003) Immunoregulation in the tissues by cd T cells. Nature Rev 3: 233–242. 13. Callebaut C, Jacotot E, Krust B, Guichard G, Blanco J, et al. (1997) Pseudopeptide TASP inhibitors of HIV infection block viral entry by binding to a 95-kDa surface protein. J Biol Chem 272: 7159–7166. 14. Nisole S, Krust B, Callebaut C, Guichard G, Muller S, et al. (1999) The anti- HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans. J Biol Chem 274: 27875–27884. P140 Peptide in Lupus Table S2 Found at: doi:10.1371/journal.pone.0005273.s014 (0.03 DOC) Table S3 Found at: doi:10.1371/journal.pone.0005273.s015 (0.04 DOC) Table S4 Found at: doi:10.1371/journal.pone.0005273.s016 (0.03 DOC) MB MB MB Acknowledgments We thank Chrystel Beaufils, Monique Duval, Bernard Lorber, and Danie`le Thierse´ for valuable assistance. We also thank Ju¨ rgen Dieker, Fre´de´ric Gros, Johan Hoebeke, and Jean-Louis Pasquali for critical reading the manuscript. We thank the Imaging facility (Plateforme Inter-Unite´s de Microscopie et d’Imagerie Cellulaire Strasbourg-Esplanade). Access to the Bruker DRX 600 NMR facilities of the Service Commun de Biophysi- cochimie des Interactions Mole´culaires of the Universite´ Henri Poincare´, Nancy I, was deeply appreciated. Author Contributions Conceived and designed the experiments: NP NS JMS OC MD MTC AVD JPB SM. Performed the experiments: NP NS JMS MQ OC MD JPB. Analyzed the data: NP NS JMS MQ OC MD MTC AVD JPB SM. Wrote the paper: JMS MTC SM. 15. Catusse J, Strub JM, Job C, Van Dorsselaer A, Job D (2008) Proteome-wide characterization of sugarbeet seed vigor and its tissue specific expression. Proc Natl Acad Sci USA 105: 10262–10276. 16. Mandell RB, Feldherr CM (1992) The effect of carboxyl-terminal deletion of thre nuclear transport rate of rat hsc70. Exp Cell Res 198: 164–169. 17. Ellis S, Killender M, Anderson RL (2000) Heat-induced alterations in the localization of Hsp72 and Hsp73 as measured by indirect immunohistochemistry and immunogold electron microscopy. J Histochem Cytochem 48: 321–331. 18. Skouri M, Delsanti M, Munch JP, Lorber B, Gie´ge´ R (1991) Dynamic light scattering studies of the aggregation of lysozyme under crystallization conditions. FEBS Lett 295: 84–88. 19. Renno T, Attinger A, Rimoldi D, Hahne M, Tschopp J, et al. (1998) Expression of B220 on activated T cell blasts recedes apoptosis. Eur J Immunol 28: 540–547. 20. Singer GG, Abbas AK (1994) The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1: 365–371. 21. Nagata S, Goldstein P (1995) The Fas death factor. Science 276: 1449–1456. 22. Ju ST, Panka DJ, Cui H, Ettinger R, EI-Khatib M, et al. (1995) Fas(CD95)/ FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444–448. 23. Thedrez A, Sabourin C, Gertner J, Devilder MC, Allain-Maillet S, et al. (2007) Self/non-self discrimination by human cd T cells: simple solutions for a complex issue? Immunol Rev 215: 123–135. 24. Peterman GM, Spencer C, Sperling AI, Bluestone JA (1993) Role of cd T cells in murine collagen-induced arthritis. J Immunol 151: 6546–6558. 25. Goodman T, Lefrancois L (1989) Intraepithelial lymphocytes. Anatomical site, not T cell receptor form, dictates phenotype and function. J Exp Med 170: 1569–1581. 26. Ito S, Ueno M, Arakawa M, Saito T, Aoyagi T, et al. (1990) Therapeutic effect of 15-deoxyspergualin on the progression of lupus nephritis in MRL mice. I. Immunopathological analyses. Clin Exp Immunol 81: 446–453. 27. Diegel ML, Nadler SG, Kiener PA (2002) In vivo administration of 15- deoxyspergulin inhibits antigen-presenting cell stimulation of T cells and NF-kB activation. Int Immunopharmacol 2: 1451–1464. 28. Lorentz HM, Grunke M, Wendler J, Heinzel PA, Kalden JR (2005) Safety of 15- deoxyspergualin in the treatment of glomerulonephritis associated with active systemic lupus erythematosus. Ann Rheum Dis 64: 1517–1519. 29. Park K, Flynn GC, Rothman JE, Fassman GD (1993) Conformational change of chaperone Hsc70 upon binding to a decapeptide: a circular dichroism study. Protein Science 2: 325–330. 30. Panjwani N, Akbari O, Garcia S, Brazil M, Stockinger B (1999) The HSC73 Molecular Chaperone: Involvement in MHC Class II Antigen Presentation. J Immunol 163: 1936–1942. PLoS ONE | www.plosone.org 12 April 2009 | Volume 4 | Issue 4 | e5273